PRAX vs VRTX · $7.38B cap vs P/E 30, rev $3.33B
Praxis Precision Medicines Inc (PRAX) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Praxis Precision Medicines Inc (PRAX) is a biotechnology company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported PRAX revenue for 2025-09-30 was $0. Net income was -$73.9M. PRAX currently screens at market cap $7.38B.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
PRAX currently screens at market cap $7.38B. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the PRAX and VRTX stock pages for the full models.
Not investment advice.